Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

May 01, 1991; Volume 39,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Audinat, E

    1. You have access
      Reduction of desensitization of a glutamate ionotropic receptor by antagonists.
      M Geoffroy, B Lambolez, E Audinat, B Hamon, F Crepel, J Rossier and R T Kado
      Molecular Pharmacology May 1991, 39 (5) 587-591;

B

  1. Barchi, R L

    1. You have access
      SkM2, a Na+ channel cDNA clone from denervated skeletal muscle, encodes a tetrodotoxin-insensitive Na+ channel.
      M M White, L Q Chen, R Kleinfield, R G Kallen and R L Barchi
      Molecular Pharmacology May 1991, 39 (5) 604-608;
  2. Barton, A C

    1. You have access
      Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells.
      A C Barton, L E Black and D R Sibley
      Molecular Pharmacology May 1991, 39 (5) 650-658;
  3. Beddell, C R

    1. You have access
      Application of pattern recognition methods to the analysis and classification of toxicological data derived from proton nuclear magnetic resonance spectroscopy of urine.
      K P Gartland, C R Beddell, J C Lindon and J K Nicholson
      Molecular Pharmacology May 1991, 39 (5) 629-642;
  4. Bernad, N

    1. You have access
      Pharmacological characterization of type B cholecystokinin binding sites on the human JURKAT T lymphocyte cell line.
      M F Lignon, N Bernad and J Martinez
      Molecular Pharmacology May 1991, 39 (5) 615-620;
  5. Black, L E

    1. You have access
      Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells.
      A C Barton, L E Black and D R Sibley
      Molecular Pharmacology May 1991, 39 (5) 650-658;
  6. Bovolin, P

    1. You have access
      Regulation of gamma-aminobutyric acidA receptor subunit expression by activation of N-methyl-D-aspartate-selective glutamate receptors.
      M Memo, P Bovolin, E Costa and D R Grayson
      Molecular Pharmacology May 1991, 39 (5) 599-603;
  7. Brüne, B

    1. You have access
      12-hydroperoxyeicosatetraenoic acid inhibits main platelet functions by activation of soluble guanylate cyclase.
      B Brüne and V Ullrich
      Molecular Pharmacology May 1991, 39 (5) 671-678;

C

  1. Chen, C H

    1. You have access
      Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity.
      C H Chen, M Vazquez-Padua and Y C Cheng
      Molecular Pharmacology May 1991, 39 (5) 625-628;
  2. Chen, L Q

    1. You have access
      SkM2, a Na+ channel cDNA clone from denervated skeletal muscle, encodes a tetrodotoxin-insensitive Na+ channel.
      M M White, L Q Chen, R Kleinfield, R G Kallen and R L Barchi
      Molecular Pharmacology May 1991, 39 (5) 604-608;
  3. Cheng, Y C

    1. You have access
      Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity.
      C H Chen, M Vazquez-Padua and Y C Cheng
      Molecular Pharmacology May 1991, 39 (5) 625-628;
  4. Costa, E

    1. You have access
      Regulation of gamma-aminobutyric acidA receptor subunit expression by activation of N-methyl-D-aspartate-selective glutamate receptors.
      M Memo, P Bovolin, E Costa and D R Grayson
      Molecular Pharmacology May 1991, 39 (5) 599-603;
  5. Crepel, F

    1. You have access
      Reduction of desensitization of a glutamate ionotropic receptor by antagonists.
      M Geoffroy, B Lambolez, E Audinat, B Hamon, F Crepel, J Rossier and R T Kado
      Molecular Pharmacology May 1991, 39 (5) 587-591;

D

  1. Di Paolo, T

    1. You have access
      Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
      D Lévesque and T Di Paolo
      Molecular Pharmacology May 1991, 39 (5) 659-665;

F

  1. Flagg, S

    1. You have access
      Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain.
      S J Wall, R P Yasuda, F Hory, S Flagg, B M Martin, E I Ginns and B B Wolfe
      Molecular Pharmacology May 1991, 39 (5) 643-649;

G

  1. Gartland, K P

    1. You have access
      Application of pattern recognition methods to the analysis and classification of toxicological data derived from proton nuclear magnetic resonance spectroscopy of urine.
      K P Gartland, C R Beddell, J C Lindon and J K Nicholson
      Molecular Pharmacology May 1991, 39 (5) 629-642;
  2. Geoffroy, M

    1. You have access
      Reduction of desensitization of a glutamate ionotropic receptor by antagonists.
      M Geoffroy, B Lambolez, E Audinat, B Hamon, F Crepel, J Rossier and R T Kado
      Molecular Pharmacology May 1991, 39 (5) 587-591;
  3. Ginns, E I

    1. You have access
      Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain.
      S J Wall, R P Yasuda, F Hory, S Flagg, B M Martin, E I Ginns and B B Wolfe
      Molecular Pharmacology May 1991, 39 (5) 643-649;
  4. Grayson, D R

    1. You have access
      Regulation of gamma-aminobutyric acidA receptor subunit expression by activation of N-methyl-D-aspartate-selective glutamate receptors.
      M Memo, P Bovolin, E Costa and D R Grayson
      Molecular Pharmacology May 1991, 39 (5) 599-603;
  5. Guthrie, T S

    1. You have access
      A synthetic pseudosubstrate peptide of protein kinase C inhibits the phorbol-12,13-dibutyrate effect on permeabilized coronary artery smooth muscle.
      T S Guthrie, J Tsuji and J N Wells
      Molecular Pharmacology May 1991, 39 (5) 621-624;

H

  1. Hamon, B

    1. You have access
      Reduction of desensitization of a glutamate ionotropic receptor by antagonists.
      M Geoffroy, B Lambolez, E Audinat, B Hamon, F Crepel, J Rossier and R T Kado
      Molecular Pharmacology May 1991, 39 (5) 587-591;
  2. Hershkowitz, N

    1. You have access
      Tetrahydroaminoacridine block of N-methyl-D-aspartate-activated cation channels in cultured hippocampal neurons.
      N Hershkowitz and M A Rogawski
      Molecular Pharmacology May 1991, 39 (5) 592-598;
  3. Hill, R J

    1. You have access
      Aminoalkyl structural requirements for interaction of lidocaine with the class I antiarrhythmic drug receptor on rat cardiac myocytes.
      R S Sheldon, R J Hill, M Taouis and L M Wilson
      Molecular Pharmacology May 1991, 39 (5) 609-614;
  4. Hory, F

    1. You have access
      Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain.
      S J Wall, R P Yasuda, F Hory, S Flagg, B M Martin, E I Ginns and B B Wolfe
      Molecular Pharmacology May 1991, 39 (5) 643-649;

K

  1. Kado, R T

    1. You have access
      Reduction of desensitization of a glutamate ionotropic receptor by antagonists.
      M Geoffroy, B Lambolez, E Audinat, B Hamon, F Crepel, J Rossier and R T Kado
      Molecular Pharmacology May 1991, 39 (5) 587-591;
  2. Kallen, R G

    1. You have access
      SkM2, a Na+ channel cDNA clone from denervated skeletal muscle, encodes a tetrodotoxin-insensitive Na+ channel.
      M M White, L Q Chen, R Kleinfield, R G Kallen and R L Barchi
      Molecular Pharmacology May 1991, 39 (5) 604-608;
  3. Kemp, J A

    1. You have access
      Effects of (+)-HA-966 and 7-chlorokynurenic acid on the kinetics of N-methyl-D-aspartate receptor agonist responses in rat cultured cortical neurons.
      J A Kemp and T Priestley
      Molecular Pharmacology May 1991, 39 (5) 666-670;
  4. Kleinfield, R

    1. You have access
      SkM2, a Na+ channel cDNA clone from denervated skeletal muscle, encodes a tetrodotoxin-insensitive Na+ channel.
      M M White, L Q Chen, R Kleinfield, R G Kallen and R L Barchi
      Molecular Pharmacology May 1991, 39 (5) 604-608;

L

  1. Lambolez, B

    1. You have access
      Reduction of desensitization of a glutamate ionotropic receptor by antagonists.
      M Geoffroy, B Lambolez, E Audinat, B Hamon, F Crepel, J Rossier and R T Kado
      Molecular Pharmacology May 1991, 39 (5) 587-591;
  2. Lévesque, D

    1. You have access
      Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
      D Lévesque and T Di Paolo
      Molecular Pharmacology May 1991, 39 (5) 659-665;
  3. Lignon, M F

    1. You have access
      Pharmacological characterization of type B cholecystokinin binding sites on the human JURKAT T lymphocyte cell line.
      M F Lignon, N Bernad and J Martinez
      Molecular Pharmacology May 1991, 39 (5) 615-620;
  4. Lindon, J C

    1. You have access
      Application of pattern recognition methods to the analysis and classification of toxicological data derived from proton nuclear magnetic resonance spectroscopy of urine.
      K P Gartland, C R Beddell, J C Lindon and J K Nicholson
      Molecular Pharmacology May 1991, 39 (5) 629-642;

M

  1. Martin, B M

    1. You have access
      Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain.
      S J Wall, R P Yasuda, F Hory, S Flagg, B M Martin, E I Ginns and B B Wolfe
      Molecular Pharmacology May 1991, 39 (5) 643-649;
  2. Martinez, J

    1. You have access
      Pharmacological characterization of type B cholecystokinin binding sites on the human JURKAT T lymphocyte cell line.
      M F Lignon, N Bernad and J Martinez
      Molecular Pharmacology May 1991, 39 (5) 615-620;
  3. Memo, M

    1. You have access
      Regulation of gamma-aminobutyric acidA receptor subunit expression by activation of N-methyl-D-aspartate-selective glutamate receptors.
      M Memo, P Bovolin, E Costa and D R Grayson
      Molecular Pharmacology May 1991, 39 (5) 599-603;

N

  1. Nicholson, J K

    1. You have access
      Application of pattern recognition methods to the analysis and classification of toxicological data derived from proton nuclear magnetic resonance spectroscopy of urine.
      K P Gartland, C R Beddell, J C Lindon and J K Nicholson
      Molecular Pharmacology May 1991, 39 (5) 629-642;

P

  1. Pessah, I N

    1. You have access
      Characterization of multiple [3H]ryanodine binding sites on the Ca2+ release channel of sarcoplasmic reticulum from skeletal and cardiac muscle: evidence for a sequential mechanism in ryanodine action.
      I N Pessah and I Zimanyi
      Molecular Pharmacology May 1991, 39 (5) 679-689;
  2. Priestley, T

    1. You have access
      Effects of (+)-HA-966 and 7-chlorokynurenic acid on the kinetics of N-methyl-D-aspartate receptor agonist responses in rat cultured cortical neurons.
      J A Kemp and T Priestley
      Molecular Pharmacology May 1991, 39 (5) 666-670;

R

  1. Rogawski, M A

    1. You have access
      Tetrahydroaminoacridine block of N-methyl-D-aspartate-activated cation channels in cultured hippocampal neurons.
      N Hershkowitz and M A Rogawski
      Molecular Pharmacology May 1991, 39 (5) 592-598;
  2. Rossier, J

    1. You have access
      Reduction of desensitization of a glutamate ionotropic receptor by antagonists.
      M Geoffroy, B Lambolez, E Audinat, B Hamon, F Crepel, J Rossier and R T Kado
      Molecular Pharmacology May 1991, 39 (5) 587-591;

S

  1. Sheldon, R S

    1. You have access
      Aminoalkyl structural requirements for interaction of lidocaine with the class I antiarrhythmic drug receptor on rat cardiac myocytes.
      R S Sheldon, R J Hill, M Taouis and L M Wilson
      Molecular Pharmacology May 1991, 39 (5) 609-614;
  2. Sibley, D R

    1. You have access
      Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells.
      A C Barton, L E Black and D R Sibley
      Molecular Pharmacology May 1991, 39 (5) 650-658;

T

  1. Taouis, M

    1. You have access
      Aminoalkyl structural requirements for interaction of lidocaine with the class I antiarrhythmic drug receptor on rat cardiac myocytes.
      R S Sheldon, R J Hill, M Taouis and L M Wilson
      Molecular Pharmacology May 1991, 39 (5) 609-614;
  2. Tsuji, J

    1. You have access
      A synthetic pseudosubstrate peptide of protein kinase C inhibits the phorbol-12,13-dibutyrate effect on permeabilized coronary artery smooth muscle.
      T S Guthrie, J Tsuji and J N Wells
      Molecular Pharmacology May 1991, 39 (5) 621-624;

U

  1. Ullrich, V

    1. You have access
      12-hydroperoxyeicosatetraenoic acid inhibits main platelet functions by activation of soluble guanylate cyclase.
      B Brüne and V Ullrich
      Molecular Pharmacology May 1991, 39 (5) 671-678;

V

  1. Vazquez-Padua, M

    1. You have access
      Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity.
      C H Chen, M Vazquez-Padua and Y C Cheng
      Molecular Pharmacology May 1991, 39 (5) 625-628;

W

  1. Wall, S J

    1. You have access
      Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain.
      S J Wall, R P Yasuda, F Hory, S Flagg, B M Martin, E I Ginns and B B Wolfe
      Molecular Pharmacology May 1991, 39 (5) 643-649;
  2. Wells, J N

    1. You have access
      A synthetic pseudosubstrate peptide of protein kinase C inhibits the phorbol-12,13-dibutyrate effect on permeabilized coronary artery smooth muscle.
      T S Guthrie, J Tsuji and J N Wells
      Molecular Pharmacology May 1991, 39 (5) 621-624;
  3. White, M M

    1. You have access
      SkM2, a Na+ channel cDNA clone from denervated skeletal muscle, encodes a tetrodotoxin-insensitive Na+ channel.
      M M White, L Q Chen, R Kleinfield, R G Kallen and R L Barchi
      Molecular Pharmacology May 1991, 39 (5) 604-608;
  4. Wilson, L M

    1. You have access
      Aminoalkyl structural requirements for interaction of lidocaine with the class I antiarrhythmic drug receptor on rat cardiac myocytes.
      R S Sheldon, R J Hill, M Taouis and L M Wilson
      Molecular Pharmacology May 1991, 39 (5) 609-614;
  5. Wolfe, B B

    1. You have access
      Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain.
      S J Wall, R P Yasuda, F Hory, S Flagg, B M Martin, E I Ginns and B B Wolfe
      Molecular Pharmacology May 1991, 39 (5) 643-649;

Y

  1. Yasuda, R P

    1. You have access
      Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain.
      S J Wall, R P Yasuda, F Hory, S Flagg, B M Martin, E I Ginns and B B Wolfe
      Molecular Pharmacology May 1991, 39 (5) 643-649;

Z

  1. Zimanyi, I

    1. You have access
      Characterization of multiple [3H]ryanodine binding sites on the Ca2+ release channel of sarcoplasmic reticulum from skeletal and cardiac muscle: evidence for a sequential mechanism in ryanodine action.
      I N Pessah and I Zimanyi
      Molecular Pharmacology May 1991, 39 (5) 679-689;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 39, Issue 5
1 May 1991
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics